“no details of what the study would entail were
Post# of 148297
(Total Views: 772)
Posted On: 10/14/2020 5:19:07 PM
“no details of what the study would entail were given, and it would be conducted in the shining beacon of objectivity and impartiality that is Mexico.”
The placebo arm of a drug trial for an indication that has an established SOC is always the SOC. There’s no arguing that. Also, there was mention of a combo trial of leronlimab and remdesevir before Mexico was discussed. Remdesevir has just been given EUA around this time.
The placebo arm of a drug trial for an indication that has an established SOC is always the SOC. There’s no arguing that. Also, there was mention of a combo trial of leronlimab and remdesevir before Mexico was discussed. Remdesevir has just been given EUA around this time.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼